心脉医疗
(688016)
| 流通市值：106.19亿 | | | 总市值：106.19亿 |
| 流通股本：1.23亿 | | | 总股本：1.23亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,118,935,318.24 | 793,949,008.92 | 370,236,154.73 | 1,350,632,689.26 |
| 营业收入 | 1,118,935,318.24 | 793,949,008.92 | 370,236,154.73 | 1,350,632,689.26 |
| 二、营业总成本 | 619,315,246.5 | 434,873,671.73 | 190,629,159.71 | 756,503,750.61 |
| 营业成本 | 291,909,278.95 | 227,424,516.15 | 99,485,697.75 | 390,570,219.08 |
| 税金及附加 | 8,961,892.2 | 7,304,089.2 | 3,214,556.93 | 12,035,723.39 |
| 销售费用 | 164,047,695.05 | 107,240,417.94 | 46,523,579.3 | 208,295,994.19 |
| 管理费用 | 53,495,559.41 | 34,616,659.54 | 17,669,812.27 | 81,956,482.53 |
| 研发费用 | 89,006,535.83 | 52,641,725.28 | 22,172,800.94 | 67,786,192.38 |
| 财务费用 | 11,894,285.06 | 5,646,263.62 | 1,562,712.52 | -4,140,860.96 |
| 其中:利息费用 | 1,167,691.29 | 295,441.87 | 142,820.25 | 2,160,567.46 |
| 其中:利息收入 | 1,864,018.35 | 3,641,186.41 | 2,311,083.28 | 10,926,722.38 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | - | - | - | 367,945.21 |
| 加:投资收益 | 11,265,004.22 | 6,428,344.82 | 2,503,627.63 | 15,976,849.83 |
| 资产处置收益 | 28,166.12 | -12,580.8 | -7,280.8 | - |
| 资产减值损失(新) | -8,777,960.65 | -5,850,335.07 | -1,769,033.71 | -9,271,248.76 |
| 信用减值损失(新) | -11,256,948.4 | -5,000,666.78 | -3,839,104.58 | -8,309,129.48 |
| 其他收益 | 26,236,585.53 | 22,392,697.43 | 3,441,210.47 | 61,110,920.57 |
| 四、营业利润 | 517,114,918.56 | 377,032,796.79 | 179,936,414.03 | 654,004,276.02 |
| 加:营业外收入 | 256,659.09 | 6,100.02 | 5,300.02 | 499,617.14 |
| 减:营业外支出 | 100,977.04 | 245,819.18 | 173,783.13 | 1,016,709.61 |
| 五、利润总额 | 517,270,600.61 | 376,793,077.63 | 179,767,930.92 | 653,487,183.55 |
| 减:所得税费用 | 79,917,507.66 | 59,274,212.27 | 27,161,866.48 | 98,827,223.89 |
| 六、净利润 | 437,353,092.95 | 317,518,865.36 | 152,606,064.44 | 554,659,959.66 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 437,353,092.95 | 317,518,865.36 | 152,606,064.44 | 554,659,959.66 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 448,565,932.84 | 322,362,360.92 | 154,841,911.99 | 563,325,654.82 |
| 少数股东损益 | -11,212,839.89 | -4,843,495.56 | -2,235,847.55 | -8,665,695.16 |
| 扣除非经常损益后的净利润 | 417,743,639.75 | 299,134,093.1 | 150,681,860.44 | 502,279,483.69 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 3.71 | 2.67 | 1.28 | 4.65 |
| (二)稀释每股收益 | 3.71 | 2.67 | 1.28 | 4.65 |
| 八、其他综合收益 | -33,267,286.62 | -25,150,577.44 | -15,396,170.5 | 26,839,274.01 |
| 归属于母公司股东的其他综合收益 | -33,267,286.62 | -25,150,577.44 | -15,396,170.5 | 26,839,274.01 |
| 九、综合收益总额 | 404,085,806.33 | 292,368,287.92 | 137,209,893.94 | 581,499,233.67 |
| 归属于母公司股东的综合收益总额 | 415,298,646.22 | 297,211,783.48 | 139,445,741.49 | 590,164,928.83 |
| 归属于少数股东的综合收益总额 | -11,212,839.89 | -4,843,495.56 | -2,235,847.55 | -8,665,695.16 |
| 公告日期 | 2026-10-30 | 2026-08-27 | 2026-04-30 | 2026-03-31 |
| 审计意见(境内) | | | | 标准无保留意见 |